Risk factor
Very high price volatility
Profitability factor
Greatly overvalued vs peers
About
Bio-Works Technologies AB (publ) is a biotechnology company that specializes in the research, development, production, and distribution of agarose-based separation products. These sophisticated solutions are designed to facilitate the purification of proteins, peptides, and other biomolecules, with a primary focus on the Swedish market. Their comprehensive product portfolio encompasses items such as activated and affinity resins, BabyBio columns, immobilized metal-ion affinity chromatography (IMAC) resins, ion exchange resins, OptioBio glass columns, screening kits, and size exclusion chromatography (SEC) resins. These offerings find use across various applications, including those concerning antibodies, His-tagged proteins, other proteins, peptides, oligonucleotides, and in the purification of viruses and vaccine development. Established in 2006, the company is headquartered in Uppsala, Sweden.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EBITD.